This inventor holds 12 USPTO granted patents. Top assignees: Microdrug Ag, Mederio Ag. Active years: 2001-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tyreso, SE (2007)
- Stockholm, SE (2001 - 2008)
Company Filing History:
Years Active: 2001-2008
Title: The Innovations of Mattias Myrman
Introduction
Mattias Myrman, a prominent inventor based in Stockholm, Sweden, has made significant contributions to the field of medicinal delivery systems. With a total of 12 patents to his name, Myrman has garnered recognition for his innovative approaches to administering medicinal dry powders, particularly through advanced inhalation techniques.
Latest Patents
Myrman’s latest patents showcase his expertise in the administration of medicinal dry powders. One of his notable inventions involves a method for delivering a metered dry powder dose via a sophisticated dry powder inhaler. This method creates relative motion between the inhaler's nozzle and a dose bed, which holds a combined dose of finely divided medication powders. By facilitating simultaneous or sequential delivery, this innovation enhances the efficacy of medication taken in a single breath.
Another significant patent revolves around securing dose quality for inhalable drugs. Myrman developed a method and device that ensures metered dry powder medication doses are accessible for inhalation while minimizing exposure to ambient air. This advancement aims to preserve the integrity and effectiveness of the medication before it reaches the patient.
Career Highlights
Throughout his career, Myrman has been affiliated with several influential companies in the pharmaceutical sector. He worked with Microdrug AG and Mederio AG, where he played key roles in advancing research and development in inhalation technology. His work has significantly impacted how medications are delivered, ultimately improving patient outcomes.
Collaborations
In his innovative journey, Myrman has collaborated with notable professionals, including Herbert Grässl and Michael Mattsson. These partnerships have fostered an environment of creativity and collective problem-solving, which is essential in the field of pharmaceuticals. Together, they have contributed to the development of advanced inhalation devices and techniques.
Conclusion
Mattias Myrman stands out as a dedicated inventor whose work in the realm of medicinal dry powders has the potential to transform patient care. His commitment to innovation and collaboration defines his legacy in medical technology. As advancements continue to emerge from his patents, the future of drug administration appears promising, ensuring patients receive their medications efficiently and effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile